DARRELL MURRAY: Open Payments
NPI 1447250170 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,986 in 21 payments from 8 companies in 2025. Trend: 2023 $1,054 · 2024 $1,089 · 2025 $1,986
Travel & lodging: $1,102Food & beverage: $884
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 9 | $1,433 |
| Novo Nordisk Inc | 2 | $247 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Indivior Inc. | 4 | $74 |
| Lundbeck LLC | 2 | $56 |
| Abbott Laboratories | 1 | $21 |
| ABBVIE INC. | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: Wegovy, BREZTRI, Ozempic, SUBLOCADE, REXULTI, FREESTYLE LIBRE 3, VRAYLAR, Kerendia.
Industry payments across GA — which companies pay providers there.
